Hospital Choice Key in Post-Myocardial Infarction Survival

Share this content:
Hospital Choice Key in Post-Myocardial Infarction Survival
Hospital Choice Key in Post-Myocardial Infarction Survival

FRIDAY, Oct. 7, 2016 (HealthDay News) -- Older patients with myocardial infarction (MI) who receive immediate high-quality care from their hospital often receive a long-term survival advantage, according to a study published in the Oct. 6 issue of the New England Journal of Medicine.

Emily Bucholz, M.D., Ph.D., M.P.H., a resident physician at Boston Children's Hospital, and colleagues reviewed 119,735 Medicare-covered MI patients treated at 1,824 hospitals across the United States between 1994 and 1996. The review included an average 17-year follow-up to track how long the patients lived. Hospitals were ranked as "high-performing" or "low-performing" based solely on the 30-day survival rates of the MI patients, who were an average of 76 years old.

The research team discovered that patients treated at high-performing hospitals had an overall increased life expectancy, compared to others treated at hospitals where more patients die during the first month of care. The average survival advantage was found to be between 0.74 and 1.14 years.

"One year is actually a fairly substantial amount of time for these patients," Bucholz told HealthDay. "From a policy level, investing in initiatives that improve short-term performance actually have long-term implications for patient outcomes."

Full Text (subscription or payment may be required)

Share this content:

is free, fast, and customized just for you!

Already a member?

Sign In Now »

Drug Lookup

Browse drugs by: BrandGenericDisease

Trending Activities

All Professions



Sign up for myCME e-newsletters


More in Home

FDA Approves First Drug for Rare Form of Rickets

FDA Approves First Drug for Rare Form of ...

Crysvita approved for adults and children ages 1 year and older with x-linked hypophosphatemia

High FGF-23 Linked to Recurrent Cardiac Events After ACS

High FGF-23 Linked to Recurrent Cardiac Events After ...

FGF-23 in top quartile independently linked to greater risk of CV death, heart failure hospitalization

Medical Cannabis Not Recommended for Sleep Apnea

Medical Cannabis Not Recommended for Sleep Apnea

American Academy of Sleep Medicine says evidence insufficient to recommend cannabis for apnea

is free, fast, and customized just for you!

Already a member?

Sign In Now »